Infectious Disease

Plenary lecture examines the immunology of COVID-19, available vaccines

April 19, 2021

1 min o’clock

Source / information

Source:

Healio interviews

Disclosure:
Koralnik does not report any relevant financial information.

ADD SUBJECT TO EMAIL ALARMS

Receive an email when new articles are published

Please enter your email address to receive an email when new articles are published . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If you continue to have this problem, please contact [email protected].

Back to Healio

In this video perspective Igor J.. Coral, MD, FAN, FANA, Review his talk on COVID-19 Immunology and COVID-19 Vaccines from the COVID-19 Plenary Session at the American Academy of Neurology Annual Meeting, which is being held virtually.

Koralnik, Chief of Neuroinfectious Diseases and Global Neurology and Professor of Neurology at Archibald Church at Northwestern University’s Feinberg School of Medicine, discussed the various methods available tests are used to detect SARS-CoV-2 and noted that it was applicable to the Diagnosis is not a “gold standard”.

“Even the newer tests that detect antibodies against the spike proteins of SARS-CoV-2 can turn out to be negative in patients who had been infected months before, as the antibody levels in the blood of patients decrease rapidly,” he said .

Koralnik discussed the “persistent and persistent” neurological problems that patients – including long-distance COVID-19 drivers – can experience. In his talk, he also discussed the vaccines against COVID-19, which immunize people against the SARS-CoV-2 spike proteins.

He discussed the different levels of effectiveness of the vaccines available and stated that “everyone should try to get vaccinated in their geographic area with vaccines that are available to them at the time.”

Koralnik described the COVID-19 vaccines as an “ongoing story” that may include a booster shot.

“It is possible that we will end up like influenza, which requires a different type of influenza vaccine each year,” he said. “Maybe we need a different type of coronavirus vaccine every year.”

ADD SUBJECT TO EMAIL ALARMS

Receive an email when new articles are published

Please enter your email address to receive an email when new articles are published . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If you continue to have this problem, please contact [email protected].

Back to Healio

American Academy of Neurology Annual Meeting

Related Articles